Inefficient Access Pathways Cost More Than Just HCP Time and Effort
There may be no greater threat to patient outcomes than the current barriers to therapy access—especially for specialty medications.
OptimizeRx Blogs
A Digital Point-of-Care Primer for Life Science Marketers
Growth in healthcare technology began with the HITECH (Health Information Technology for Economic and Clinical Health) Act of 2009 and has grown significantly over the years....
Discover Patients (and Their Providers) When They Are Poised to Change Therapies
Every day, patients switch to new therapies because of disease progression, side effects, affordability or other factors—potentially delaying patient recoveries, negatively...
The RWD Win/Win: A Strategy that Delivers for Pharma, Patients, HCPs and More
Over the past decade, pharma has made significant investments in real-world data (RWD) and in analytics/insights generated from that data. At OptimizeRx, we’re applying this...
Reducing Misdiagnosis with AI-Driven Patient Journey Mapping
It’s a problem with an enormous impact on patients that has been nearly impossible to solve: Brand-eligible patients are out there, but they’ve been misdiagnosed or, even...
Implementing a Practical Approach to AI and Real World Data that Improves Care Journeys
Offering a Practical Approach to AI and Real World Data
Despite incredible advances in the availability of real-world data (RWD) and AI applications, many tech-savvy brand...
Patient Journey Planning: Learn How to Make a Great First Impression for Your Brand
Exploring the Current State of Patient Journey Planning
In the quest to improve patient outcomes, life sciences companies are increasing their focus on optimizing the patient...
Dynamic HCP Targeting — Here's the Secret to AI in Pharma Marketing
AI in Pharma Marketing is a Hot Topic – But Execution Lags Behind Ideation
If you’re a life science marketer, chances are you’ve been hearing about the difference artificial...
Addressing Equal Opportunity to Learn About Support
Pharma manufacturers work relentlessly to create drugs and therapies to address some of the most complex health conditions people face. There are years of research and...
Innovate4Outcomes®: Patient Advocates Come to the Table
Innovate4Outcomes® was born in 2020 as a design-thinking event in response to COVID-19, but it quickly became clear the COVID-19 health crisis could be a catalyst for a...
HCP Targeting: Be there when your ideal patient and provider meet
Unlocking the Full Potential with Artificial Intelligence in Pharma Marketing
At the recent Re:Imagine Pharma Marketing virtual conference, I was excited to present on how...
Overcoming Challenges Related to Multiple Sclerosis Treatment: The Complete Picture
Key Themes and Takeways from Our Multiple Sclerosis Series
In our series on the challenges MS patients face in starting and staying on therapy, we’ve explored three key areas...